An abattoir saves the day

An abattoir saves the day By Stephen Pincock Article Extras Swiss Structures When Timm Maier arrived at Nenad Ban's lab at ETH Zurich in early 2004, he was looking for a project that would push him to his limits. Not long before, ETH's Simon Jenni had obtained well-diffracting crystals of fungal fatty acid synthase, so Maier decided to go after its mammalian analogue. Justin Hession Photography /www.justinhession.ch Nenad Ban (left) and T

Written byStephen Pincock
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

By Stephen Pincock

Swiss Structures

When Timm Maier arrived at Nenad Ban's lab at ETH Zurich in early 2004, he was looking for a project that would push him to his limits. Not long before, ETH's Simon Jenni had obtained well-diffracting crystals of fungal fatty acid synthase, so Maier decided to go after its mammalian analogue.

"It was a funny project," says the German-born protein crystallographer, who completed his PhD at the Free University in Berlin. Since the 1970s, other groups had repeatedly shown that "it was impossible to obtain diffraction-quality crystals," he says.

But Maier needed to jump over another hurdle before he could even start trying to grow crystals: He needed a good source of the protein. "Expression of the molecule is difficult in E. coli," he explains, "and I didn't want to get into decades of trying to clone it and express it."

After pondering the problem ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies